1. Phase I‐II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma. (22nd August 2014) Authors: Reece, Donna E.; Masih‐Khan, Esther; Atenafu, Eshetu G.; Jimenez‐Zepeda, Victor H.; Anglin, Peter; Chen, Christine; Kukreti, Vishal; Mikhael, Joseph R.; Trudel, Suzanne Journal: British journal of haematology Issue: Volume 168:Number 1(2015:Jan.) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗